Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21 )

Blood

Volumn 106, Issue 3, 2005, Pages 1037-1041

  Yeh, Kun Huei ^c   Kuo, Sung Hsin ^c   Chen, Li Tzong ^b   Mao, Tsui Lien ^c   Doong, Shin Lian ^c   Wu, Ming Shiang ^c   Hsu, Hui Chen ^c   Tzeng, Yi Shin ^c   Chen, Chi Long ^c   Lin, Jaw Town ^c   Cheng, Ann Lii ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METRONIDAZOLE; PROTEIN BCL 10; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY;

EID: 23044470306     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-01-0004     Document Type: Article

References (32)

1. Wotherspoon AC, Ortiz Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175-1176.
2. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267-1271.
3. Du MQ, Isaacson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 2002; 3:97-104.
4. Liu H, Ruskone Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet. 2000;357:39-40
5. Liu H, Ye H, Ruskone-Fourmestraux A, et al. t(11; 18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology. 2002;122:1286-1294.
6. Kaneko Y, Sakurai S, Hironaka M, et al. Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas. Gut. 2003;52:641-646.
7. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B-cell lymphoma and mutated in multiple tumor types. Cell. 1999;96:35-45.
8. Zhang Q, Siebert R, Yan M, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet. 1999;22:63-68.
9. Ye H, Dogan A, Karran L, et al. BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma. Am J Pathol. 2000;157:1147-1154.
10. Du MQ, Peng HZ, Liu H, et al. BCL10 mutation in lymphoma. Blood. 2000;95:3885-3890.
11. Maes B, Demunter A, Peeters B, et al. BCL10 gene mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MALT1 fusion is associated with aberrant nuclear BCL10 expression. Blood. 2002;99:1398-1403.
12. Ohshima K, Muta H, Kawasaki C, etal. Bcl10 expression rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappa B. Int J Oncol. 2001;19:283-289.
13. Liu H, Ye H, Dogan A, et al. t(11;18)(q21;q21) is associated with advanced mucosa associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood. 2001;98:1182-1187.
14. Ruland J, Duncan GS, Elia A. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure. Cell. 2001;104: 33-42.
15. Xue L, Morris SW, Orihuela C, et al. Defective development and function of BCL10-deficient follicular, marginal zone and B1 B cells. Nat Immunol. 2004;4:857-865.
16. Uren GA, O'Rourke K, Aravind L, et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell. 2000;6:961-967.
17. Karin M, Cao Y, Greten FR, Li ZW. NF-kappa B in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301-310.
18. Chen LT, Lin JT, Shyu RY, et al. Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol. 2001;19:4245-4251.
19. Kuo SH, Chen LT, Yeh KH, et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol. 2004; 22:3491-3497.
20. Baens M, Maes B, Steyls A, et al. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am J Pathol. 2000;156: 1433-1439.
21. Inagaki H, Okabe M, Seto M, et al. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol. 2001;158:699-706.
22. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol. 1990;136:1153-1164.
23. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas [in German]. Strahlentherapie. 1977;153:218-221.
24. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577.
25. Dierlamm J, Baens M, Wtodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11; 18) (q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood. 1999;93: 3601-3609.
26. Okabe M, Inagaki H, Ohshima K, et al. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Pathol. 2003;162:1113-1122.
27. Ye H, Liu H, Raderer M, et al. High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood. 2003;101:2547-2550.
28. McAllister-Lucas LM, Inohara N, Lucas PC, et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-κB induction. J Biol Chem. 2001;276:30589-30597.
29. Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem. 2001;276:19012-19019.
30. Zhou H, Wertz I, O'Rourke K, et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO. Nature. 2004;427:167-171.
31. Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood. 2003;102:1012-1018.
32. Streubel B, Simonitsch-Klupp I, Mullauer L, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia. 2004;18:1722-1726.